Separate terms with OR to return results that match either term.
 
Clear All
9,752 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date (Ascending) Status
71329-0303-01 71329-0303 Methylprednisolone Methylprednisolone Sodium Succinate 500.0 mg/8mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous April 20, 2021 In Use
71329-0304-01 71329-0304 Methylprednisolone Methylprednisolone Sodium Succinate 1.0 g/16mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous April 20, 2021 In Use
71329-0305-01 71329-0305 Methylprednisolone Methylprednisolone Sodium Succinate 2.0 g/30.6mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous April 20, 2021 In Use
71731-5111-01 71731-5111 Fosaprepitant dimeglumine Fosaprepitant 150.0 mg/5mL Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Intravenous March 16, 2021 In Use
71731-6121-01 71731-6121 Fulvestrant Fulvestrant 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular April 1, 2021 In Use
72064-0110-30 72064-0110 avapritinib Ayvakit 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor PDGFR, KIT, CSFR1 Oral Jan. 9, 2020 In Use
72064-0120-30 72064-0120 avapritinib Ayvakit 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor PDGFR, KIT, CSFR1 Oral Jan. 9, 2020 In Use
72064-0125-30 72064-0125 avapritinib Ayvakit 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor PDGFR, KIT, CSFR1 Oral Jan. 9, 2020 In Use
72064-0130-30 72064-0130 avapritinib Ayvakit 300.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor PDGFR, KIT, CSFR1 Oral Jan. 9, 2020 In Use
72064-0150-30 72064-0150 avapritinib Ayvakit 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor PDGFR, KIT, CSFR1 Oral Jan. 9, 2020 In Use
72893-0004-01 72893-0004 Levoleucovorin KHAPZORY 175.0 mg/3.5mL Ancillary Therapy Chemoprotective Antidote Intravenous Jan. 2, 2019 In Use
72893-0006-01 72893-0006 Levoleucovorin KHAPZORY 300.0 mg/6mL Ancillary Therapy Chemoprotective Antidote Intravenous Jan. 2, 2019 In Use
78206-0147-01 78206-0147 trastuzumab Ontruzant 150.0 mg/1 Immunotherapy Monoclonal Antibody HER2 Intravenous June 1, 2021 In Use
81561-0413-05 81561-0413 asparaginase ERWINASE 10000.0 [iU]/mL Chemotherapy Miscellaneous Agent Enzyme Intramuscular, Intravenous June 1, 2021 In Use
00008-1179-01 00008-1179 Temsirolimus Torisel Chemotherapy Enzyme Inhibitor mTOR Intravenous July 1, 2007 In Use
00024-5824-11 00024-5824 Cabazitaxel Jevtana Chemotherapy Antimitotic Agent Taxane Intravenous June 17, 2010 In Use
00074-0579-28 00074-0579 Venetoclax Venclexta Chemotherapy Enzyme Inhibitor BCL-2 Oral April 11, 2016 In Use
00078-0715-02 00078-0715 Alpelisib PIQRAY Chemotherapy Enzyme Inhibitor PI3K Oral May 24, 2019 In Use
00078-0715-91 00078-0715 Alpelisib PIQRAY Chemotherapy Enzyme Inhibitor PI3K Oral May 24, 2019 In Use
00078-0909-61 00078-0909 Ribociclib and letrozole Kisqali Femara Co-pack Chemotherapy, Hormonal Therapy Cyclin Dependent Kinase Inhibitor CDK 4/6 + Hormonal Oral May 4, 2017 In Use
00078-0916-61 00078-0916 letrozole and ribociclib Kisqali Femara Co-pack Chemotherapy, Hormonal Therapy Cyclin Dependent Kinase Inhibitor CDK 4/6 + Hormonal Oral May 4, 2017 In Use
00078-0923-61 00078-0923 letrozole and ribociclib Kisqali Femara Co-pack Chemotherapy, Hormonal Therapy Cyclin Dependent Kinase Inhibitor CDK 4/6 + Hormonal Oral May 4, 2017 In Use
50742-0477-01 50742-0477 MELPHALAN HYDROCHLORIDE MELPHALAN HYDROCHLORIDE Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Feb. 18, 2020 In Use
52609-3001-00 52609-3001 Melphalan Hydrochloride Alkeran Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jan. 1, 2011 In Use
54288-0106-03 54288-0106 Melphalan Hydrochloride Melphalan Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Sept. 30, 2020 In Use
54879-0036-64 54879-0036 Carmustine Carmustine Chemotherapy Alkylating Agent Nitrosourea Intravenous May 16, 2019 In Use
59572-0984-01 59572-0984 Romidepsin Istodax Chemotherapy Enzyme Inhibitor HDAC Intravenous Jan. 4, 2010 In Use
62856-0714-05 62856-0714 Lenvatinib Lenvima Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral Feb. 13, 2015 In Use
62856-0714-30 62856-0714 Lenvatinib Lenvima Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral Feb. 13, 2015 In Use
62856-0718-05 62856-0718 Lenvatinib Lenvima Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral May 17, 2016 In Use
62856-0718-30 62856-0718 Lenvatinib Lenvima Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral May 13, 2016 In Use
62856-0724-05 62856-0724 Lenvatinib Lenvima Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral Feb. 13, 2015 In Use
62856-0724-30 62856-0724 Lenvatinib Lenvima Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral Feb. 13, 2015 In Use
63323-0175-30 63323-0175 Oxaliplatin Oxaliplatin Chemotherapy Alkylating Agent Platinum Compound Intravenous Sept. 17, 2009 In Use
63323-0176-50 63323-0176 Oxaliplatin Oxaliplatin Chemotherapy Alkylating Agent Platinum Compound Intravenous Sept. 17, 2009 In Use
63323-0760-20 63323-0760 Melphalan Hydrochloride Melphalan Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Dec. 22, 2017 In Use
67457-0195-01 67457-0195 Melphalan Hydrochloride Melphalan Hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jan. 10, 2013 In Use
67457-0215-01 67457-0215 Melphalan Hydrochloride Melphalan Hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jan. 10, 2013 In Use
67457-0579-01 67457-0579 Melphalan Hydrochloride Melphalan Hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Sept. 29, 2014 In Use
68475-0503-01 68475-0503 carmustine Carmustine Chemotherapy Alkylating Agent Nitrosourea Intravenous Dec. 29, 2020 In Use
69605-0103-03 69605-0103 Mitomycin JELMYTO Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Instillation May 1, 2020 In Use
70020-1910-01 70020-1910 Ixabepilone Ixempra Chemotherapy Antitumor Antibiotic Epothilones Intravenous Oct. 16, 2007 In Use
70121-1482-02 70121-1482 carmustine carmustine Chemotherapy Alkylating Agent Nitrosourea Intravenous Oct. 22, 2018 In Use
70700-0278-97 70700-0278 Melphalan hydrochloride Melphalan hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jan. 6, 2021 In Use
70710-1525-09 70710-1525 Carmustine Carmustine Chemotherapy Alkylating Agent Nitrosourea Intravenous Dec. 24, 2020 In Use
72266-0128-01 72266-0128 Melphalan hydrochloride Melphalan hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Sept. 23, 2019 In Use
72493-0103-03 72493-0103 Mitomycin JELMYTO Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Instillation May 1, 2020 In Use
72611-0779-02 72611-0779 Melphalan hydrochloride Melphalan hydrochloride Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Nov. 1, 2020 In Use
72611-0785-02 72611-0785 Temsirolimus Injection Temsirolimus Chemotherapy Enzyme Inhibitor mTOR Intravenous May 8, 2020 In Use
68001-0551-41 68001-0551 Pemetrexed disodium Pemetrexed 500.0 mg/20mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Sept. 7, 2022 In Use

Found 9,752 results in 9 milliseconds — Export these results